{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:28:33Z","timestamp":1792024113620,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-09693-3","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T08:30:23Z","timestamp":1723192223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["HPV specificity and multiple infections and association with cervical cytology in Chongqing, China: a cross-sectional study"],"prefix":"10.1186","volume":"24","author":[{"given":"Qinli","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghua","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"issue":"3","key":"9693_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"9693_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1159\/000448385","volume":"39","author":"P Hillemanns","year":"2016","unstructured":"Hillemanns P, Soergel P, Hertel H, Jentschke M. Epidemiology and Early Detection of Cervical Cancer. Oncol Res Treat. 2016;39(9):501\u20136.","journal-title":"Oncol Res Treat"},{"issue":"6","key":"9693_CR3","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz N, Bosch FX, de Sanjos\u00e9 S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518\u201327.","journal-title":"N Engl J Med"},{"issue":"1","key":"9693_CR4","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1186\/s12885-021-08703-w","volume":"21","author":"G Zhong","year":"2021","unstructured":"Zhong G, Wang Y, Xie Q, Lin R, Yao T. HPV-specific risk assessment of cervical cytological abnormalities. BMC Cancer. 2021;21(1):949.","journal-title":"BMC Cancer"},{"issue":"1","key":"9693_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.virol.2010.02.002","volume":"401","author":"HU Bernard","year":"2010","unstructured":"Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010;401(1):70\u20139.","journal-title":"Virology."},{"issue":"7","key":"9693_CR6","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1158\/1055-9965.EPI-06-0129","volume":"15","author":"H Trottier","year":"2006","unstructured":"Trottier H, Mahmud S, Costa MC, et al. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev. 2006;15(7):1274\u201380.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"9693_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ygyno.2014.03.552","volume":"133","author":"EL Dickson","year":"2014","unstructured":"Dickson EL, Vogel RI, Geller MA, Downs LS Jr. Cervical cytology and multiple type HPV infection: a study of 8182 women ages 31\u201365. Gynecol Oncol. 2014;133(3):405\u20138.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"9693_CR8","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ijc.25396","volume":"128","author":"N Li","year":"2011","unstructured":"Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer. 2011;128(4):927\u201335.","journal-title":"Int J Cancer"},{"issue":"1","key":"9693_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ygyno.2010.03.007","volume":"118","author":"KD Sjoeborg","year":"2010","unstructured":"Sjoeborg KD, Trop\u00e9 A, Lie AK, et al. HPV genotype distribution according to severity of cervical neoplasia. Gynecol Oncol. 2010;118(1):29\u201334.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"9693_CR10","doi-asserted-by":"publisher","first-page":"e0280437","DOI":"10.1371\/journal.pone.0280437","volume":"18","author":"Y Nartey","year":"2023","unstructured":"Nartey Y, Amo-Antwi K, Hill PC, et al. Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana. PLoS ONE. 2023;18(1):e0280437.","journal-title":"PLoS ONE"},{"issue":"10316","key":"9693_CR11","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","volume":"398","author":"M Falcaro","year":"2021","unstructured":"Falcaro M, Casta\u00f1on A, Ndlela B, et al. The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study. Lancet. 2021;398(10316):2084\u201392.","journal-title":"Lancet"},{"issue":"7","key":"9693_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","volume":"7","author":"S de Sanjos\u00e9","year":"2007","unstructured":"de Sanjos\u00e9 S, Diaz M, Castellsagu\u00e9 X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7(7):453\u20139.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"9693_CR13","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.21873\/invivo.13314","volume":"37","author":"M Cenci","year":"2023","unstructured":"Cenci M, Rossi F, Pisani T. Detection of 14 High-risk Human Papillomavirus (HPV) Genotypes Within the Italian Cervical Cancer Screening. In Vivo. 2023;37(5):2161\u20135.","journal-title":"In Vivo"},{"issue":"2","key":"9693_CR14","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191\u2013203.","journal-title":"Lancet Glob Health"},{"issue":"4","key":"9693_CR15","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/infdis\/jiaa709","volume":"226","author":"I Laake","year":"2022","unstructured":"Laake I, Feiring B, Jonassen CM, et al. Concurrent Infection With Multiple Human Papillomavirus Types Among Unvaccinated and Vaccinated 17-Year-Old Norwegian Girls. J Infect Dis. 2022;226(4):625\u201333.","journal-title":"J Infect Dis"},{"issue":"9","key":"9693_CR16","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.31557\/APJCP.2021.22.9.2729","volume":"22","author":"JO Okoye","year":"2021","unstructured":"Okoye JO, Chukwukelu CF, Okekpa SI, Ogenyi SI, Onyekachi-Umah IN, Ngokere AA. Racial Disparities Associated with the Prevalence of Vaccine and Non-Vaccine HPV Types and Multiple HPV Infections between Asia and Africa: A Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev. 2021;22(9):2729\u201341.","journal-title":"Asian Pac J Cancer Prev"},{"key":"9693_CR17","doi-asserted-by":"publisher","first-page":"1105468","DOI":"10.3389\/fonc.2023.1105468","volume":"13","author":"L Ji","year":"2023","unstructured":"Ji L, Chen M, Yao L. Strategies to eliminate cervical cancer in China. Front Oncol. 2023;13:1105468.","journal-title":"Front Oncol"},{"key":"9693_CR18","doi-asserted-by":"crossref","unstructured":"You D, Han L, Li L, et al. Human Papillomavirus (HPV) Vaccine Uptake and the Willingness to Receive the HPV Vaccination among Female College Students in China: A Multicenter Study. Vaccines (Basel). 2020;8(1):31.","DOI":"10.3390\/vaccines8010031"},{"issue":"1","key":"9693_CR19","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s12879-018-3175-9","volume":"18","author":"N Thapa","year":"2018","unstructured":"Thapa N, Maharjan M, Shrestha G, et al. Prevalence and type-specific distribution of human papillomavirus infection among women in mid-western rural, Nepal- A population-based study. BMC Infect Dis. 2018;18(1):338.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"9693_CR20","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/cncr.32003","volume":"125","author":"K Li","year":"2019","unstructured":"Li K, Li Q, Song L, Wang D, Yin R. The distribution and prevalence of human papillomavirus in women in mainland China. Cancer. 2019;125(7):1030\u20137.","journal-title":"Cancer"},{"issue":"3","key":"9693_CR21","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/jmv.24352","volume":"88","author":"Z Baloch","year":"2016","unstructured":"Baloch Z, Yuan T, Wang B, et al. Ethnic and geographic variations in HPV prevalence and genotype distribution in north-western Yunnan. China J Med Virol. 2016;88(3):532\u201340.","journal-title":"China J Med Virol"},{"issue":"2","key":"9693_CR22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","volume":"24","author":"RB Perkins","year":"2020","unstructured":"Perkins RB, Guido RS, Castle PE, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020;24(2):102\u201331.","journal-title":"J Low Genit Tract Dis"},{"issue":"1","key":"9693_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28414","volume":"95","author":"A Ros\u00e1rio","year":"2023","unstructured":"Ros\u00e1rio A, Sousa A, Marinho-Dias J, et al. Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program. J Med Virol. 2023;95(1): e28414.","journal-title":"J Med Virol"},{"issue":"8","key":"9693_CR24","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1158\/1055-9965.EPI-22-0054","volume":"31","author":"A Bukowski","year":"2022","unstructured":"Bukowski A, Hoyo C, Hudgens MG, et al. Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States. Cancer Epidemiol Biomarkers Prev. 2022;31(8):1564\u201371.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"9693_CR25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12985-018-1003-x","volume":"15","author":"W Long","year":"2018","unstructured":"Long W, Yang Z, Li X, et al. HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in Southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix. Virol J. 2018;15(1):94.","journal-title":"Virol J"},{"issue":"11","key":"9693_CR26","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1007\/s00705-020-04771-8","volume":"165","author":"K Ju\u00e1rez-Gonz\u00e1lez","year":"2020","unstructured":"Ju\u00e1rez-Gonz\u00e1lez K, Paredes-Cervantes V, Gordillo-Rodr\u00edguez S, et al. High prevalence of human papillomavirus type 66 in low-grade cervical lesions of Mexican women. Arch Virol. 2020;165(11):2633\u201340.","journal-title":"Arch Virol"},{"key":"9693_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.820517","volume":"10","author":"EL Wong","year":"2022","unstructured":"Wong EL, Cheung AW, Chen Z, et al. Molecular Epidemiology of Human Papillomavirus Infection Among Chinese Women With Cervical Cytological Abnormalities. Front Public Health. 2022;10: 820517.","journal-title":"Front Public Health"},{"issue":"8","key":"9693_CR28","doi-asserted-by":"publisher","first-page":"e0182854","DOI":"10.1371\/journal.pone.0182854","volume":"12","author":"ML Nogueira Dias Genta","year":"2017","unstructured":"Nogueira Dias Genta ML, Martins TR, Mendoza Lopez RV, et al. Multiple HPV genotype infection impact on invasive cervical cancer presentation and survival. PLoS One. 2017;12(8):e0182854.","journal-title":"PLoS One."},{"key":"9693_CR29","doi-asserted-by":"crossref","unstructured":"Kim M, Park NJ, Jeong JY, Park JY. Multiple Human Papilloma Virus (HPV) Infections Are Associated with HSIL and Persistent HPV Infection Status in Korean Patients. Viruses. 2021;13(7):1342.","DOI":"10.3390\/v13071342"},{"issue":"13","key":"9693_CR30","doi-asserted-by":"publisher","first-page":"14794","DOI":"10.1002\/cam4.6109","volume":"12","author":"A Bai","year":"2023","unstructured":"Bai A, Xue P, Li Q, Jiang Y, Qiao Y. Diagnostic value of high-risk HPV other than type 16\/18 in high-grade cervical neoplasia among cytology-negative women: A multicenter retrospective study. Cancer Med. 2023;12(13):14794\u2013805.","journal-title":"Cancer Med"},{"issue":"7","key":"9693_CR31","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1093\/infdis\/jiq139","volume":"203","author":"AK Chaturvedi","year":"2011","unstructured":"Chaturvedi AK, Katki HA, Hildesheim A, et al. Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis. 2011;203(7):910\u201320.","journal-title":"J Infect Dis"},{"issue":"11","key":"9693_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187844","volume":"12","author":"R Senapati","year":"2017","unstructured":"Senapati R, Nayak B, Kar SK, Dwibedi B. HPV genotypes co-infections associated with cervical carcinoma: Special focus on phylogenetically related and non-vaccine targeted genotypes. PLoS ONE. 2017;12(11): e0187844.","journal-title":"PLoS ONE"},{"issue":"11","key":"9693_CR33","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1093\/aje\/kwu267","volume":"180","author":"Z Yang","year":"2014","unstructured":"Yang Z, Cuzick J, Hunt WC, Wheeler CM. Concurrence of multiple human papillomavirus infections in a large US population-based cohort. Am J Epidemiol. 2014;180(11):1066\u201375.","journal-title":"Am J Epidemiol"},{"key":"9693_CR34","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3389\/fonc.2020.00449","volume":"10","author":"G Liao","year":"2020","unstructured":"Liao G, Jiang X, She B, et al. Multi-Infection Patterns and Co-infection Preference of 27 Human Papillomavirus Types Among 137,943 Gynecological Outpatients Across China. Front Oncol. 2020;10:449.","journal-title":"Front Oncol"},{"issue":"7","key":"9693_CR35","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1097\/IGC.0b013e31829e9fb4","volume":"23","author":"EL Dickson","year":"2013","unstructured":"Dickson EL, Vogel RI, Bliss RL, Downs LS Jr. Multiple-type human papillomavirus (HPV) infections: a cross-sectional analysis of the prevalence of specific types in 309,000 women referred for HPV testing at the time of cervical cytology. Int J Gynecol Cancer. 2013;23(7):1295\u2013302.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"9693_CR36","doi-asserted-by":"publisher","first-page":"2343192","DOI":"10.1080\/21645515.2024.2343192","volume":"20","author":"M Wang","year":"2024","unstructured":"Wang M, Liang H, Yan Y, et al. Distribution of HPV types among women with HPV-related diseases and exploration of lineages and variants of HPV 52 and 58 among HPV-infected patients in China: A systematic literature review. Hum Vaccin Immunother. 2024;20(1):2343192.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"9693_CR37","doi-asserted-by":"publisher","first-page":"2329450","DOI":"10.1080\/21645515.2024.2329450","volume":"20","author":"C Zhao","year":"2024","unstructured":"Zhao C, Zhao Y, Li J, Li M, Shi Y, Wei L. Opportunities and challenges for human papillomavirus vaccination in China. Hum Vaccin Immunother. 2024;20(1):2329450.","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"9693_CR38","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/infdis\/jiaa032","volume":"224","author":"I Man","year":"2021","unstructured":"Man I, V\u00e4nsk\u00e4 S, Lehtinen M, Bogaards JA. Human Papillomavirus Genotype Replacement: Still Too Early to Tell. J Infect Dis. 2021;224(3):481\u201391.","journal-title":"J Infect Dis"},{"issue":"1","key":"9693_CR39","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3892\/ol.2016.4668","volume":"12","author":"S Fischer","year":"2016","unstructured":"Fischer S, Bettstetter M, Becher A, et al. Shift in prevalence of HPV types in cervical cytology specimens in the era of HPV vaccination. Oncol Lett. 2016;12(1):601\u201310.","journal-title":"Oncol Lett"},{"issue":"7","key":"9693_CR40","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1093\/infdis\/jiz280","volume":"220","author":"JA Bogaards","year":"2019","unstructured":"Bogaards JA, van der Weele P, Woestenberg PJ, van Benthem B, King AJ. Bivalent Human Papillomavirus (HPV) Vaccine Effectiveness Correlates With Phylogenetic Distance From HPV Vaccine Types 16 and 18. J Infect Dis. 2019;220(7):1141\u20136.","journal-title":"J Infect Dis"},{"key":"9693_CR41","doi-asserted-by":"publisher","first-page":"1130226","DOI":"10.3389\/fmicb.2023.1130226","volume":"14","author":"Y Shen","year":"2023","unstructured":"Shen Y, Huang Y, Wang W, et al. Prevalence and genotype distribution of HPV infection among women in Xiamen. China Front Microbiol. 2023;14:1130226.","journal-title":"China Front Microbiol"},{"issue":"9","key":"9693_CR42","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.3390\/vaccines11091466","volume":"11","author":"M Butt\u00e0","year":"2023","unstructured":"Butt\u00e0 M, Serra N, Panzarella V, Fasciana T, Campisi G, Capra G. Orogenital Human Papillomavirus Infection and Vaccines: A Survey of High- and Low-Risk Genotypes Not Included in Vaccines. Vaccines (Basel). 2023;11(9):1466.","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"9693_CR43","doi-asserted-by":"publisher","first-page":"e0230640","DOI":"10.1371\/journal.pone.0230640","volume":"15","author":"S Hao","year":"2020","unstructured":"Hao S, Wang C, Liu S, He J, Jiang Y. HPV genotypic spectrum in Jilin province, China, where non-vaccine-covered HPV53 and 51 are prevalent, exhibits a bimodal age-specific pattern. PLoS ONE. 2020;15(3):e0230640.","journal-title":"PLoS ONE"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09693-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09693-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09693-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T09:13:39Z","timestamp":1723194819000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09693-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,9]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9693"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09693-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,9]]},"assertion":[{"value":"21 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients were informed and signed informed consent voluntarily. This study was approved by the ethics committee of Chongqing University Cancer Hospitaland complied with the guidelines outlined in the declaration of Helsinki were followed. The written consent was received from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"804"}}